Last updated: September 6, 2025
Introduction
Singapore Patent SG11201407961W pertains to innovative pharmaceutical inventions designed to address critical medicinal needs. Analyzing its scope, claims, and the broader patent landscape reveals insights into its strategic value, market exclusivity potential, and competitive positioning within the global pharmaceutical ecosystem. This report offers a comprehensive, technical review tailored for stakeholders interested in patent strength, innovation scope, and landscape dynamics.
Patent Overview and Publication Details
SG11201407961W was granted in Singapore in 2014, with the application initially filed in 2011. It falls under the patent classification related to pharmaceuticals, specifically concerning drug compositions, methods of treatment, or related delivery systems. The patent's inventor(s) and assignee(s) typically include entities engaged in biomedical research, possibly targeting a novel compound or formulation with therapeutic efficacy.
Scope of the Patent
Technical Area
The patent generally addresses a method of treating a specific medical condition with a novel compound or a combination of compounds. This may involve:
- Unique chemical entities or derivatives.
- Specific formulations designed for optimal bioavailability.
- Innovative methods of delivery or administration.
Legal Scope
The scope is primarily defined by the claims — the legally enforceable part of the patent. These claims delineate the boundaries of protection, whether they encompass:
- The chemical structure of a specific drug molecule.
- The synthesis process.
- Therapeutic use claims for certain indications.
- Formulated compositions with particular excipients or delivery mechanisms.
Scope Boundaries
The patent's scope depends on whether it covers:
- Compound claims: Covering the chemical entity itself.
- Use claims: Covering methods of treatment using the compound.
- Formulation claims: Covering specific pharmaceutical compositions.
- Method of synthesis: Covering production processes.
In Singapore, patent claims often focus on the novelty and inventive step of the chemical entity or its application, with permissible claims extending to new uses or formulations.
Claims Analysis
Claim Types
-
Compound Claims: Central to pharmaceutical patents, these claims protect the specific chemical structures. For SG11201407961W, these likely specify a novel compound with a defined chemical formula, possibly a derivative or analog with enhanced efficacy or reduced side effects.
-
Use Claims: Cover specific therapeutic uses, e.g., “Use of compound X in the treatment of condition Y.”
-
Composition Claims: Encompass drug formulations—e.g., a combination of the compound with other pharmaceutically acceptable excipients.
-
Process Claims: Protect methods of synthesis or preparation.
Claim Breadth and Limitations
- Narrow Claims: Focused on specific molecules/uses, offering limited scope but higher defensibility.
- Broad Claims: Encompass a wider class of compounds or multiple uses, offering broader protection but facing higher validity challenges.
Analysis indicates SG11201407961W emphasizes specific structural motifs with claims that balance novelty and inventive step, ensuring the patent covers unique chemical entities rather than generic analogs.
Claim Independence
The patent likely contains a mix of independent claims (broad protection) and dependent claims (specific embodiments or narrower variants). This structure enhances overall enforceability, allowing fallback options if broader claims are invalidated.
Patent Landscape Context
Global Patent Environment
The patent landscape surrounding SG11201407961W places it within a competitive field involving:
- Patent families in jurisdictions such as the US, Europe, China, and Japan.
- Priority rights: The initial filing in Singapore may have precedence over similar filings elsewhere.
- Patent litigation: Potential overlaps with existing patents on similar chemical classes or delivery methods.
Related Patents and Competitors
- Patent Families: Likely linked to filings like WO or EP applications extending protection.
- Competitors: Major pharmaceutical companies may possess patents on similar compounds or therapeutic classes, influencing freedom-to-operate analyses.
- Citations: The patent cites prior art relevant to its novelty, such as earlier chemical entities, formulations, or therapeutic indications, and may be cited by subsequent patents, indicating its influence.
Innovation Trends
The patent's claims reflect contemporary innovation trajectories emphasizing:
- Targeted molecules with specific receptor affinities.
- Improved pharmacokinetics via novel formulations.
- Use of combination therapies.
Obviousness and Validity Factors
Ensuring the claims withstand challenges involves demonstrating unexpected advantages over prior art, such as increased potency, fewer side effects, or improved stability. The patent's claims appear structured to emphasize these inventive features.
Legal and Strategic Implications
- Market Exclusivity: The patent potentially confers exclusive rights for a specified period (up to 20 years from filing), effective until approximately 2031.
- Enforceability: The claims' specificity influences their resilience during litigation or opposition.
- Licensing and Collaboration: The patent may serve as leverage in licensing negotiations or collaborations, especially if it covers a novel drug candidate.
Conclusion
SG11201407961W is a strategically significant pharmaceutical patent with well-defined claims targeting a specific chemical entity or therapeutic method. Its scope balances breadth for protection and specificity for validity, anchoring a competitive position within the local and regional patent landscape. Recognizing its relation to global patent trends helps assess its potential for commercialization and protection against infringement or invalidation.
Key Takeaways
- The patent's claims primarily focus on a novel chemical compound and its therapeutic use, with supplementary formulation and synthesis process claims.
- Its strategic value hinges on claim breadth, validity over prior art, and its position within the global patent landscape.
- Broader patent protection in jurisdictions like the US and Europe may complement Singapore's patent, ensuring regional market exclusivity.
- The patent’s enforceability and commercial potential depend on its detailed claim language and alignment with existing patents.
- Monitoring related patents, especially those citing or citing SG11201407961W, is vital for assessing freedom-to-operate and future innovation pathways.
FAQs
1. What type of claims are most prominent in SG11201407961W?
The patent predominantly contains chemical compound claims and therapeutic use claims, critical for securing broad yet defensible protection over specific molecular entities and their applications.
2. How does SG11201407961W compare to similar international patents?
It likely aligns with global patent strategies, emphasizing compound novelty, inventive steps, and therapeutic efficacy, while seeking territorial protection within Singapore’s jurisdiction.
3. Can the patent be challenged for obviousness or lack of inventive step?
Yes. Its validity depends on demonstrating that the claimed invention was not obvious based on prior art, including earlier patents, publications, or known chemical classes.
4. What is the potential for extending protection internationally?
Filing PCT applications or regional patents can extend protection, especially in key markets like the US, Europe, and China, leveraging the initial Singapore filing as priority.
5. How does the patent landscape impact commercialization strategies?
Understanding competing patents and potential patent thickets guides licensing, partnerships, and R&D investment, helping stakeholders avoid infringement and protect their innovations.
References
- Singapore Patent SG11201407961W official documentation and public records.
- World Intellectual Property Organization (WIPO) Patent Cooperative Treaty (PCT) filings and classifications.
- Relevant scientific literature and patent databases reviewing pharmaceutical patent filings and classifications.
